1. Home
  2. PLRX vs ECX Comparison

PLRX vs ECX Comparison

Compare PLRX & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • ECX
  • Stock Information
  • Founded
  • PLRX 2015
  • ECX 2017
  • Country
  • PLRX United States
  • ECX China
  • Employees
  • PLRX N/A
  • ECX N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • ECX EDP Services
  • Sector
  • PLRX Health Care
  • ECX Technology
  • Exchange
  • PLRX Nasdaq
  • ECX Nasdaq
  • Market Cap
  • PLRX 682.2M
  • ECX 584.9M
  • IPO Year
  • PLRX 2020
  • ECX N/A
  • Fundamental
  • Price
  • PLRX $11.07
  • ECX $1.84
  • Analyst Decision
  • PLRX Strong Buy
  • ECX
  • Analyst Count
  • PLRX 7
  • ECX 0
  • Target Price
  • PLRX $40.50
  • ECX N/A
  • AVG Volume (30 Days)
  • PLRX 544.0K
  • ECX 1.6M
  • Earning Date
  • PLRX 02-26-2025
  • ECX 02-26-2025
  • Dividend Yield
  • PLRX N/A
  • ECX N/A
  • EPS Growth
  • PLRX N/A
  • ECX N/A
  • EPS
  • PLRX N/A
  • ECX N/A
  • Revenue
  • PLRX N/A
  • ECX $778,608,168.00
  • Revenue This Year
  • PLRX N/A
  • ECX $20.12
  • Revenue Next Year
  • PLRX N/A
  • ECX $32.70
  • P/E Ratio
  • PLRX N/A
  • ECX N/A
  • Revenue Growth
  • PLRX N/A
  • ECX 25.45
  • 52 Week Low
  • PLRX $10.22
  • ECX $0.96
  • 52 Week High
  • PLRX $18.92
  • ECX $3.09
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 36.41
  • ECX 43.42
  • Support Level
  • PLRX $10.94
  • ECX $1.78
  • Resistance Level
  • PLRX $12.70
  • ECX $1.97
  • Average True Range (ATR)
  • PLRX 0.77
  • ECX 0.13
  • MACD
  • PLRX -0.18
  • ECX -0.02
  • Stochastic Oscillator
  • PLRX 4.69
  • ECX 12.39

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About ECX ECARX Holdings Inc. Ordinary shares

ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services primarily in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.

Share on Social Networks: